Checked
Federal dataHealth
Dactinomycin
Published by U.S. Food and Drug Administration · Updated 03/17/2025 · Yearly
- Last updated
- 03/17/2025
- First published 09/16/2016
- Update frequency
- Yearly
- Formats
- Web only
- Coverage
- Nationwide
- Federal data
About this dataset
Dactinomycin is a prescription injectable drug, available as a lyophilized powder for intravenous use. Manufactured by Meitheal Pharmaceuticals Inc., it contains 0.5 mg of dactinomycin per vial and belongs to the actinomycin class, acting as an inhibitor of nucleic acid and protein synthesis. This generic version (ANDA213463) is used in medical treatments and was approved for marketing in November 2020. This information was generated using AI and is provided for informational and research purposes only.
Files and access
Links open the official government source
- Dactinomycinaccessdata.fda.govWeb page
Links open outside websites we do not control.
Frequently asked questions
- Who publishes Dactinomycin?
- U.S. Food and Drug Administration, part of U.S. Department of Health & Human Services, publishes this dataset on Data.gov.
- How often is it updated?
- The publisher lists the update frequency as yearly. The last update was on 03/17/2025.
- How do I download it?
- Use the official source link above to view or request the data.
Similar data from other publishers
- DactinomycinState of VirginiaDactinomycin is a prescription injectable drug, available as a lyophilized powder for intravenous use. Manufactured by Meitheal Pharmaceuticals Inc., it contains 0.5 mg of dactinomycin per vial and belongs to the actinomycin class, acting as an inhibitor of nuUpdated 07/06/2026
- DactinomycinState of VirginiaDactinomycin is a prescription injectable medication used in chemotherapy to treat certain cancers by inhibiting nucleic acid and protein synthesis. It comes as a lyophilized powder for intravenous injection, with each vial containing 0.5 mg, manufactured by XUpdated 03/24/2026
- DactinomycinState of VirginiaDactinomycin is a prescription injectable drug, available as a lyophilized powder for intravenous use. Manufactured by Meitheal Pharmaceuticals Inc., it contains 0.5 mg of dactinomycin per vial and belongs to the actinomycin class, acting as an inhibitor of nuUpdated 03/24/2026
- DactinomycinState of VirginiaDactinomycin is a prescription injectable medication used in chemotherapy to treat certain cancers by inhibiting nucleic acid and protein synthesis. It comes as a lyophilized powder for intravenous injection, with each vial containing 0.5 mg, manufactured by XUpdated 07/06/2026
- DaptomycinState of VirginiaDaptomycin is an antibiotic medication used to treat serious bacterial infections, such as those in the skin, soft tissues, or bloodstream. It belongs to the lipopeptide class and is administered intravenously as a powder that is mixed into a solution before uUpdated 03/24/2026
Where this catalog comes from
- Data.gov CatalogU.S. General Services Administration
- State and local open data portalsSocrata Discovery API
- State and city CKAN portalsCalifornia, Virginia, Boston, Houston and more
- Government ArcGIS Hub sitesCity and county GIS data
Catalog checked 10/24/2026
We list dataset descriptions only. Downloads and APIs link straight to the official government source, which holds the current version and its terms of use.
Source: Data.gov · Last updated 10/24/2026 · Listing only; the data stays with the publisher
Share: